202 related articles for article (PubMed ID: 19439303)
21. Neopterin as an Effect Modifier of the Cardiovascular Risk Predicted by Total Homocysteine: A Prospective 2-Cohort Study.
Bjørnestad EØ; Borsholm RA; Svingen GFT; Pedersen ER; Seifert R; Midttun Ø; Ueland PM; Tell GS; Bønaa KH; Nygård O
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29097387
[TBL] [Abstract][Full Text] [Related]
22. Elevated serum C-reactive protein levels predict cardiovascular events in the Japanese coronary artery disease (JCAD) study.
Shimada K; Fujita M; Tanaka A; Yoshida K; Jisso S; Tanaka H; Yoshikawa J; Kohro T; Hayashi D; Okada Y; Yamazaki T; Nagai R;
Circ J; 2009 Jan; 73(1):78-85. PubMed ID: 19015587
[TBL] [Abstract][Full Text] [Related]
23. Inflammatory Obesity Phenotypes, Gender Effects, and Subclinical Atherosclerosis in African Americans: The Jackson Heart Study.
Lin A; Lacy ME; Eaton C; Correa A; Wu WC
Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2431-2438. PubMed ID: 27856456
[TBL] [Abstract][Full Text] [Related]
24. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.
Ridker PM; Danielson E; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Koenig W; Libby P; Lorenzatti AJ; Macfadyen JG; Nordestgaard BG; Shepherd J; Willerson JT; Glynn RJ;
Lancet; 2009 Apr; 373(9670):1175-82. PubMed ID: 19329177
[TBL] [Abstract][Full Text] [Related]
25. Predictive significance of plasma levels of interleukin-6 and high-sensitivity C-reactive protein in atrial fibrillation after coronary artery bypass surgery.
Ucar HI; Tok M; Atalar E; Dogan OF; Oc M; Farsak B; Guvener M; Yilmaz M; Dogan R; Demircin M; Pasaoglu I
Heart Surg Forum; 2007; 10(2):E131-5. PubMed ID: 17597037
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-6 level is a powerful predictor of long-term cardiovascular mortality in patients with acute coronary syndrome.
Gager GM; Biesinger B; Hofer F; Winter MP; Hengstenberg C; Jilma B; Eyileten C; Postula M; Lang IM; Siller-Matula JM
Vascul Pharmacol; 2020 Dec; 135():106806. PubMed ID: 33035661
[TBL] [Abstract][Full Text] [Related]
27. Prognostic values of C-reactive protein levels on clinical outcome after implantation of sirolimus-eluting stents in patients on hemodialysis.
Ishii H; Toriyama T; Aoyama T; Takahashi H; Amano T; Hayashi M; Tanaka M; Kawamura Y; Yasuda Y; Yuzawa Y; Maruyama S; Matsuo S; Matsubara T; Murohara T
Circ Cardiovasc Interv; 2009 Dec; 2(6):513-8. PubMed ID: 20031768
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
[TBL] [Abstract][Full Text] [Related]
29. Biochemical markers in patients with open reconstructions with peripheral arterial disease.
Stone PA; Thompson SN; Williams D; AbuRahma Z; Grome L; Schlarb H; AbuRahma AF
Vascular; 2016 Oct; 24(5):461-8. PubMed ID: 26462536
[TBL] [Abstract][Full Text] [Related]
30. Mortality risk prediction of high-sensitivity C-reactive protein in suspected acute coronary syndrome: A cohort study.
Kaura A; Hartley A; Panoulas V; Glampson B; Shah ASV; Davies J; Mulla A; Woods K; Omigie J; Shah AD; Thursz MR; Elliott P; Hemmingway H; Williams B; Asselbergs FW; O'Sullivan M; Lord GM; Trickey A; Sterne JA; Haskard DO; Melikian N; Francis DP; Koenig W; Shah AM; Kharbanda R; Perera D; Patel RS; Channon KM; Mayet J; Khamis R
PLoS Med; 2022 Feb; 19(2):e1003911. PubMed ID: 35192610
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of circulating leukocyte subtype counts in patients with coronary artery disease.
Yamamoto E; Sugiyama S; Hirata Y; Tokitsu T; Tabata N; Fujisue K; Sugamura K; Sakamoto K; Tsujita K; Matsumura T; Kaikita K; Hokimoto S
Atherosclerosis; 2016 Dec; 255():210-216. PubMed ID: 27612676
[TBL] [Abstract][Full Text] [Related]
32. hsCRP Level and the Risk of Death or Recurrent Cardiovascular Events in Patients With Myocardial Infarction: a Healthcare-Based Study.
Carrero JJ; Andersson Franko M; Obergfell A; Gabrielsen A; Jernberg T
J Am Heart Assoc; 2019 Jun; 8(11):e012638. PubMed ID: 31140334
[TBL] [Abstract][Full Text] [Related]
33. Effect of high-sensitivity C-reactive protein on the relationship between haemoglobin A1c and cardiovascular events in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a cohort study.
Li Y; He S; Liu T; Cheng Z; Wang C; Shi Y; Liu J
Cardiovasc Diagn Ther; 2022 Oct; 12(5):614-625. PubMed ID: 36329961
[TBL] [Abstract][Full Text] [Related]
34. Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome: A CT Coronary Angiography Study.
Vaidya K; Arnott C; Martínez GJ; Ng B; McCormack S; Sullivan DR; Celermajer DS; Patel S
JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):305-316. PubMed ID: 29055633
[TBL] [Abstract][Full Text] [Related]
35. Plasma adiponectin levels in relation to prognosis in patients with angiographic coronary artery disease.
Li Q; Lu Y; Sun L; Yan J; Yan X; Fang L; Li M; Fan Z
Metabolism; 2012 Dec; 61(12):1803-8. PubMed ID: 22789446
[TBL] [Abstract][Full Text] [Related]
36. Plasma myeloperoxidase predicts incident cardiovascular risks in stable patients undergoing medical management for coronary artery disease.
Tang WH; Wu Y; Nicholls SJ; Hazen SL
Clin Chem; 2011 Jan; 57(1):33-9. PubMed ID: 21059827
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
Roman RM; Camargo PV; Borges FK; Rossini AP; Polanczyk CA
Coron Artery Dis; 2010 May; 21(3):129-36. PubMed ID: 20305551
[TBL] [Abstract][Full Text] [Related]
38. Association Between High-Sensitivity C-Reactive Protein and Total Stroke by Hypertensive Status Among Men.
Jiménez MC; Rexrode KM; Glynn RJ; Ridker PM; Gaziano JM; Sesso HD
J Am Heart Assoc; 2015 Sep; 4(9):e002073. PubMed ID: 26391131
[TBL] [Abstract][Full Text] [Related]
39. High high-sensitivity C-reactive protein/BMI ratio predicts future adverse outcomes in patients with acute coronary syndrome.
Jia L; Yuan JQ; Zhu L; Zhang Y
Coron Artery Dis; 2019 Sep; 30(6):448-454. PubMed ID: 31386638
[TBL] [Abstract][Full Text] [Related]
40. Longitudinal High-Sensitivity C-Reactive Protein and Longer-Term Cardiovascular Outcomes in Optimally-Treated Patients With High-Risk Vascular Disease.
Dykun I; Clark D; Carlo J; Lincoff AM; Menon V; Nissen SE; Nicholls SJ; Puri R
Am J Cardiol; 2022 Oct; 181():1-8. PubMed ID: 35970631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
